Elan Corporation, a specialist pharmaceuticals group based in Ireland, has made a successful £420 million ($700 million) bid for California-based pharmaceuticals company Neurex. The acquisition marks the company's first step into the US hospitals market. Elan is making the transformation from a research company to a drugs group.
May 31 1998